Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MACITENTAN\TADALAFIL for Pulmonary hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where MACITENTAN\TADALAFIL was used for Pulmonary hypertension.

Most Reported Side Effects for MACITENTAN\TADALAFIL

Side Effect Reports % Deaths Hosp.
Headache 75 13.6% 0 12
Dyspnoea 56 10.2% 1 16
Product dose omission issue 46 8.4% 0 3
Hospitalisation 42 7.6% 3 40
Dizziness 32 5.8% 0 10
Death 30 5.5% 23 4
Diarrhoea 29 5.3% 0 12
Fatigue 25 4.6% 0 5
Adverse drug reaction 24 4.4% 0 1
Hypotension 22 4.0% 0 9
Nausea 21 3.8% 0 9
Fluid retention 16 2.9% 0 8
Arthralgia 15 2.7% 0 6
Swelling 15 2.7% 0 3
Vomiting 15 2.7% 0 6

Other Indications for MACITENTAN\TADALAFIL

Product used for unknown indication (380) Pulmonary arterial hypertension (135)

Other Drugs Used for Pulmonary hypertension

AMBRISENTAN (18,885) TREPROSTINIL (10,034) MACITENTAN (5,228) RIOCIGUAT (3,837) SILDENAFIL (3,761) SELEXIPAG (2,500) EPOPROSTENOL (2,486) TADALAFIL (2,430) BOSENTAN (2,337) ILOPROST (1,123)

Related Pages

MACITENTAN\TADALAFIL Full Profile All Pulmonary hypertension Drugs MACITENTAN\TADALAFIL Demographics MACITENTAN\TADALAFIL Timeline